US court orders Guardant Health to pay $245 million for cancer patent infringement A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Gua
Open in BitSocialBitSocial — the social app with no off switch